Latest filing published 29 Oct 2026 for Vesalius Longevity Labs Inc., €230k.
Insider track record
No signal scores available.
Kevin Andrew Mayer: trading record in brief
Kevin Andrew Mayer is a declared insider of Vesalius Longevity Labs Inc., with filings sourced from SEDI. Altogether 3 filings, all relating to 28 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 29 October 2026, the filings show an option exercise worth €230k in Vesalius Longevity Labs Inc. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.
Companies and markets linked to Kevin Andrew Mayer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 600,000 shares@ CA$0.60OptionsTSXSEDI:4795496
- OptionsTSXSEDI:4795495
- Common SharesTSXSEDI:4795494
3 of 3 declarations